Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDestiny Pharma. Share News (DEST)

Share Price Information for Destiny Pharma. (DEST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 16.25
Bid: 15.50
Ask: 17.00
Change: 0.50 (3.17%)
Spread: 1.50 (9.677%)
Open: 15.75
High: 16.25
Low: 15.75
Prev. Close: 15.75
DEST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Brickability buys Leadcraft; Aquis has record July

Mon, 02nd Aug 2021 11:39

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

Brickability Group PLC - Bracknell, Berkshire-based construction materials distributor - Buys Leadcraft Ltd for GBP5.5 million. Leadcraft is a roofing contractor based in Hampshire. "Leadcraft is Brickability's 12th strategically significant acquisition in the last three years and, following the recent transaction with Taylor Maxwell, further underlines the acquisition strategy set out at listing," Brickability says. Company will pay an initial GBP3.3 million before GBP2.2 million in deferred consideration, GBP900,000 of which is based on performance targets. Leadcraft recorded GBP5.6 million in revenue in the year that ended June 30.

----------

Aquis Exchange PLC - London-based operator of Aquis Stock Exchange - Says core Aquis Exchange division achieves monthly market share of pan-European trading of 6.2% in July, a record showing for company. "I am delighted that Aquis Exchange has achieved another key milestone in market share across a month of trading. Against the backdrop of Covid-19 uncertainty, I am particularly encouraged by this step-up in Aquis Exchange's market share," Chief Executive Officer Alasdair Haynes says.

----------

Science in Sport PLC - Nelson, England-based nutrition company - Launches 'Life', a "major new product range" within its PhD Nutrition brand. "The new range marks a significant expansion of PhD's offering and has been designed as a comprehensive range of premium supplements that optimise both physical and mental well-being," Science in Sport adds. Range includes products for gut health, mental performance as well as metabolic wellness. "It is expected to appeal to a wide range of consumers, including both PhD's core active lifestyle audience and those interested in broader well-being," company says.

----------

Voyager Life PLC - Perth, Scotland-based supplier of cannabidiol and hemp seed oil products for use in health and wellness industry - Opens first retail store in St Andrews, Scotland. Notes store is in prime location and sells range of CBD and hemp products as well as providing takeaway hot drinks. Store opened on July 31 and "traded profitably over the weekend". Also enters into exclusive distribution agreement with D Atkinson Herbalist & Clinic, trading as Napiers, based in Edinburgh.

----------

Angus Energy PLC - oil and gas development company - Preparing to resume production operations in the Saltfleetby gas field. "The process facility detailed design has resumed and is at an advanced stage. Long lead equipment has been ordered and bespoke processing units have been tendered," Angus adds. Notes rig tender selection completed and tenders for associated equipment expected in "forthcoming week". At Lidsey Field, company says Environment Agency confirms side-track can be drilled, though Angus says it is unlikely to be carried out before 2022. Finally, at Balcombe, Angus has further talks with West Sussex County Council and plans to appeal committee decision to reject bid for short well test.

----------

Oriole Resources PLC - mineral explorer in Senegal and Cameroon - Says mapping and stream sediment sampling continues at Central Licence Package in Cameroon. Initial results expected in third quarter of 2021. "Mapping and sampling over the remaining three licences in the west of the package will resume in Q4 2021," Oriole adds.

----------

Xtract Resources PLC - London-based gold miner with assets in southern Africa and Australia - Updates on second phase drilling at Bushranger copper-gold project in Australia. Notes second angled hole completed. Well-mineralised zone of copper spotted. "Drilling of more steeply angled hole BRDD-21-010 is underway," Xtract adds.

----------

Petro Matad Ltd - Mongolia-based oil exploration company - Receives USD2.1 million subscription proceeds from Petrovis Matad Inc. Petrovis is Petro's founding and major shareholder. In addition, Petro says it uses part of proceeds from a share placing to repay Petrovis USD459,000 in loan principal and interest.

----------

Rambler Metals & Mining PLC - Canada-focused copper and gold producer - Updates on drilling at Ming Mine in Newfoundland. Says initial results from ongoing diamond drill programme show "multiple intersections of high-grade copper". Rambler plans to update the resource definition for Ming Mine to include the drill data.

----------

Camellia PLC - Linton, England-based agricultural production firm - Buys 80% stake in Bardsley England, the UK's second largest apple supplier, for GBP15.7 million. Also provides GBP9.3 million loan to Bardsley. Fruit farming firm Bardsley operates 850 hectares of land in Kent. Land includes 27 orchards growing apples, pears and cherries. "Bardsley is an innovator in the use of agritech, employing technology such as micro-climate sensors to monitor for adverse weather and wet leaf sensors to give early indication of pests and disease. It also uses a combination of trailer-mounted machine vision devices and remote satellite technology to improve yield predictions and crop management," Camellia says.

----------

Henry Boot PLC - Sheffield, England-based construction and property development business - Forming joint venture with Factory, a technology campus developer. The new JV, to be called HBD X Factory, has been selected to provide 45-hectare work at Golden Valley Development by Cheltenham Borough Council in UK. Henry Boot says: "The Golden Valley Development covers 200-acres and is expected to create 12,000 new jobs, 3,700 new homes, and 2 million square feet of commercial space, with Cyber Central UK at the heart of a visionary integrated campus focused on cyber and digital innovation." Adds: "The project builds on the presence of GCHQ's headquarters and Cheltenham's existing cyber sector, with the first phase delivering an innovative, mixed use community clustered around Factory's first project of scale in the UK - Factory Cheltenham - which will sit alongside GCHQ."

----------

Foresight Group Holdings Ltd - infrastructure and private equity investment manager - Notes further interim close of Foresight Energy Infrastructure Partners, a Europe-focused sustainability-led energy infrastructure fund. Gets EUR71 million in new commitments. "The fund has made four investments to date, two construction greenfield wind assets, an operating wind farm and an energy-from-waste plant. All assets have been independently assessed for compliance with the EU Green Taxonomy and each asset acquired by the fund will also be certified," Foresight adds. Has a total capital pool of EUR957 million.

----------

RTW Venture Fund Ltd - investment company focused on the life sciences sector - Portfolio firm Tenaya Therapeutics Inc upsizes initial public offering on Nasdaq Global Market. Heart diseases-focused biotechnology company RTW raises USD180 million from placing of 12 million shares at USD15 each. On first day of trading, Tenaya rose 2.3% to close at USD15.35.

----------

Cordiant Digital Infrastructure Ltd - investment firm focused on digital infrastructure assets - Investment manager performs due diligence of "several investment opportunities", including two North American data centre platforms and a multi-asset tower in Europe. Also includes "a European fibre and tower platform, and three European data centre platforms". Cordiant adds: "The investment manager determined not to proceed with one of the European data centre platforms in consequence of pricing considerations. In certain instances, processes have been slowed as a result of unforeseen developments on the vendor side."

----------

D4t4 Solutions PLC - Surrey-based data management company - Acquires Bristol, UK-based data and analytics consultancy Prickly Cactus for up to GBP750,000. Prickly provides digital transformation consulting services and has previously had "strategic relationship with D4t4". Company adds: "With their many years of experience in key industry verticals, such as financial services and insurance, the addition of the Prickly Cactus team is expected to have a positive impact on the group's performance." In addition, D4t4 names Ashoni Mehta as chief financial officer from September 1. Mehta has previously served on boards of London-listed Rosslyn Data Technologies PLC and Northbridge Industrial Services PLC. Interim CFO Nitil Patel remains at company until end of September to ensure orderly handover.

----------

Tribal Group PLC - Bristol-based education software and services firm - Wins cloud contract deals worth GBP7.1 million in total. Signs five-year GBP3.5 million deal with University of Warwick for migration of its student management system and seals deals with Solent University and University of West London for Tribal's SITS:Vision database application. Also wins University of Leiden, Netherlands deal for Tribal cloud scheduling product

----------

Destiny Pharma PLC - Brighton, England-based biotechnology firm - Says additional data from probe of XF-73 shows patients benefitted from "sustained bacterial reduction" in three post-surgery time points of one hour, two days and six days after wound closure. "We are very pleased to announce this additional, positive data from the successful Phase 2b study of XF-73 as a novel drug to reduce the incidence of post-surgical infections such as MRSA," CEO Neil Clark adds.

----------

Totally PLC - Derby-based provider of healthcare services to the NHS - Handed urgent care deal worth GBP4 million per year. To provide urgent treatment centre on behalf of King's College Hospital NHS Foundation Trust. "The contract will run for a period of three years, with an option to extend for a further two years. Plans to mobilise the new service are already underway in preparation for commencement of the contract," Totally adds.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
29 Jun 2023 18:55

TRADING UPDATES: Ecofin US Renewables expects to pay reduced dividend

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Thursday and not separately reported by Alliance News:

Read more
26 May 2023 10:51

Polarean shares down despite narrowed annual loss and optimism

(Alliance News) - Polarean Imaging PLC shares were down on Friday despite slimming its annual loss, as the company said it now will focus on gaining commercial traction and exploring further financing for its newly US Food & Drug Administration-approved Xenoview device.

Read more
25 May 2023 10:42

IN BRIEF: Destiny Pharma picks interim CEO as Clark makes quick exit

Destiny Pharma PLC - Brighton, England-based clinical-stage biotechnology company focused on preventing life-threatening infections - Chief Executive Officer Neil Clark steps down immediately "to pursue new challenges". Clark will "support [Destiny] for a limited period to ensure an orderly handover." Non-Executive Director Debra Barker will serve as interim CEO until Destiny appoints a permanent replacement. Barker has held "key roles" at Novartis AG and Polyphor AG, now named Spexis AG. She also has previously worked at Roche Holding AG, Polyneuron Pharmaceuticals AG and GSK PLC.

Read more
18 May 2023 15:03

UK shareholder meetings calendar - next 7 days

Friday 19 May 
Bank of Georgia Group PLCAGM
Permanent TSB Group Holdings PLCAGM
Sancus Lending Group LtdAGM
Monday 22 May 
Blackrock Latin American Investment Trust PLCAGM
Crossword Cybersecurity PLCAGM
Judges Scientific PLCAGM
Stelrad Group PLCAGM
Venture Life Group PLCAGM
Tuesday 23 May 
888 Holdings PLCAGM
Access Intelligence PLCAGM
Arix Bioscience PLCAGM
Bank of Ireland Group PLCAGM
Big Technologies PLCAGM
Bigblu Broadband PLCAGM
Centamin PLCAGM
CT Private Equity Trust PLCAGM
Empresaria Group PLCAGM
Epwin Group PLCAGM
Forterra PLCAGM
Fresnillo PLCAGM
Fulcrum Utility Services LtdGM re issue of conversion shares
Gresham Technologies PLCAGM
Harworth Group PLCAGM
Hilton Food Group PLCAGM
hVIVO PLCAGM
HydrogenOne Capital Growth PLCAGM
IQ-AI LtdAGM
JTC PLCAGM
K3 Business Technology Group PLCAGM
Pebble Group PLCAGM
Portmeirion Group PLCAGM
PPHE Hotel Group LtdAGM
Restaurant Group PLCAGM
Shell PLCAGM
Sherborne Investors (Guernsey) C LtdAGM
TMT Investments PLCAGM
Triple Point Income VCT PLCAGM
Triple Point Social Housing REIT PLCAGM
Trustpilot Group PLCAGM
Twentyfour Income Fund LtdAGM
Wickes Group PLCAGM
Xeros Technology Group PLCAGM
Wednesday 24 May 
4imprint Group PLCAGM
Adriatic Metals PLCAGM
Arbuthnot Banking Group PLCAGM
Artisanal Spirits Co PLCAGM
Bango PLCAGM
Coca-Cola Europacific Partners PLCAGM
Deliveroo PLCAGM
Deltic Energy PLCAGM
Distribution Finance Capital Holdings PLCAGM
Dunedin Enterprise Investment Trust PLCAGM
ECSC Group PLCCourt and General Meetings re Daisy Corporate Services Trading Ltd takeover
Empiric Student Property PLCAGM
Fidelity Japan Trust PLCAGM
HICL Infrastructure PLCAGM
Horizonte Minerals PLCAGM
Intertek Group PLCAGM
Ithaca Energy PLCAGM
Kelso Group Holdings PLCAGM
Lookers PLCAGM
M&G PLCAGM
Mercantile Investment Trust PLCAGM
Microlise Group PLCAGM
Mortgage Advice Bureau Holdings PLCAGM
National World PLCAGM
Ondine Biomedical IncAGM
Petershill Partners PLCAGM
Playtech PLCAGM
Quarto Group IncAGM
Real Estate Investors PLCAGM
Tullow Oil PLCAGM
US Solar Fund PLCAGM
Zotefoams PLCAGM
Thursday 25 May 
Alliance Pharma PLCAGM
Biome Technologies PLCAGM
Capital & Regional PLCAGM
Destiny Pharma PLCAGM
Ferrexpo PLCAGM
Fevertree Drinks PLCAGM
Headlam Group PLCAGM
Henry Boot PLCAGM
Hill & Smith PLCAGM
LBG Media PLCAGM
Life Science REIT PLCAGM
LSL Property Services PLCAGM
NAHL Group PLCAGM
Petrofac LtdAGM
Pharos Energy PLCAGM
Prudential PLCAGM
Regional REIT LtdAGM
Resolute Mining LtdAGM
RM PLCAGM
S&U PLCAGM
Sabre Insurance Group PLCAGM
Schroder Asian Total Return Investment Co PLCAGM
TBC Bank Group PLCAGM
Vanquis Banking Group PLCAGM
Zinc Media Group PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
2 May 2023 19:22

TRADING UPDATES: Macfarlane buys A&G Holdings for GBP3.6 million

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
13 Apr 2023 14:16

Destiny Pharma loss widens as it extends cash runway

(Sharecast News) - Biotechnology company Destiny Pharma reported a loss before tax of £7.7m in its 2022 results on Thursday, widening from £6.3m in the prior year.

Read more
13 Apr 2023 13:59

IN BRIEF: Destiny Pharma annual loss widens as expenses grow

Destiny Pharma PLC - Brighton, England-based clinical-stage biotechnology - Pretax loss widens to GBP7.7 million for 2022 from GBP6.3 million in 2021. Administrative expenses increase to GBP7.4 million from GBP6.0 million a year earlier. Research & development expenditure amounts to GBP4.9 million, up from GBP3.7 million in 2021. Looking ahead, Destiny Pharma says it will focus on completing the manufacturing scale-up to deliver clinical trial material for the NTCD-M3 clinical programme being run by our partner Sebela. Chief Executive Officer Neil Clark says: "Destiny Pharma has made good progress in 2022 and in the first quarter of 2023."

Read more
6 Apr 2023 15:42

UK earnings, trading statements calendar - next 7 days

Friday 7 April 
no events scheduled 
Monday 10 April 
no events scheduled 
Tuesday 11 April 
Devolver Digital IncFull Year Results
JTC PLCFull Year Results
Wednesday 12 April 
Argentex Group PLCQ3 Results
DP Eurasia NVFull Year Results
Everyman Media Group PLCFull Year Results
LBG Media PLCFull Year Results
Tharisa PLCTrading Statement
Thursday 13 April 
Brooks Macdonald Group PLCTrading Statement
Churchill China PLCFull Year Results
Destiny Pharma PLCFull Year Results
discoverIE Group PLCTrading Statement
Foresight Group Holdings LtdTrading Statement
Imperial Brands PLCTrading Statement
LSL Property Services PLCFull Year Results
Norcros PLCTrading Statement
PZ Cussons PLCTrading Statement
Tesco PLCFull Year Results
XP Power LtdTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
4 Apr 2023 11:33

Destiny Pharma upbeat on infection prevention study

(Sharecast News) - Destiny Pharma said in an update on Tuesday that its novel medicine for preventing life-threatening infections, 'NTCD-M3', had been shown to colonise the gut successfully in a C difficile infection (CDI) model study after the administration of fidaxomicin.

Read more
24 Mar 2023 15:34

Destiny publishes 'important' research on its preoperative treatment candidate

(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma announced the publication of landmark clinical data for 'XF-73' on Friday, in the US-based peer-reviewed journal Infection Control & Hospital Epidemiology.

Read more
16 Mar 2023 06:54

IN BRIEF: Destiny Pharma raises GBP7.3 million total in equity raise

Destiny Pharma PLC - Brighton, England-based clinical-stage biotechnology - Gets 33% take-up of open offer of shares, raising GBP340,000. Destiny raises GBP7.3 million gross in total from the open offer, plus a share placing and subscription, all at 35 pence per share. Net proceeds are GBP6.7 million, which will be used to support a collaboration agreement in the US with Sebela Pharmaceuticals for NTCD-M3, Destiny's lead asset for the prevention of clostridioides difficile infection recurrence.

Read more
24 Feb 2023 14:28

Destiny shares fall on fundraise discount despite USD570 million deal

(Alliance News) - Destiny Pharma PLC on Friday said that it has signed a collaboration agreement with Sebela Pharmaceuticals for NTCD-M3, its lead asset for the prevention of clostridioides difficile infection recurrence.

Read more
25 Jan 2023 20:03

TRADING UPDATES: Appreciate gets court date; Corcel completes sale

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
22 Dec 2022 14:06

Destiny Pharma jumps on 2022 progress

(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma updated the market on its progress in 2022 on Thursday, including working to finalise a partnering agreement for 'NTCD-M3', which it described as its "most advanced" clinical programme, targeted at infection prevention.

Read more
22 Dec 2022 12:10

LONDON MARKET MIDDAY: UK stocks rise as Paris and Frankfurt head lower

(Alliance News) - Stock prices in London were higher at midday on Thursday, ahead of some key US economic data, while equities elsewhere were less buoyant.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.